James Hocker to Adult
                            
                            
                                This is a "connection" page, showing publications James Hocker has written about Adult.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.394
         
        
        
     
 
    
        
        - 
            Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery. PLoS One. 2020; 15(8):e0234539.
            
            
                Score: 0.072
            
         
        
        - 
            Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
            
            
                Score: 0.049
            
         
        
        - 
            Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
            
            
                Score: 0.046
            
         
        
        - 
            Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals. Cancer Invest. 2012 Feb; 30(2):189-97.
            
            
                Score: 0.040
            
         
        
        - 
            Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and control individuals using serum profiling. Cancer Invest. 2012 Feb; 30(2):180-8.
            
            
                Score: 0.040
            
         
        
        - 
            Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer. 2011 Nov; 74(2):206-11.
            
            
                Score: 0.038
            
         
        
        - 
            Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling. Cancer Invest. 2011 Feb; 29(2):173-9.
            
            
                Score: 0.037
            
         
        
        - 
            Distinguishing patients with idiopathic epilepsy from solitary cysticercus granuloma epilepsy and biochemical phenotype assessment using a serum biomolecule profiling platform. PLoS One. 2020; 15(8):e0237064.
            
            
                Score: 0.018
            
         
        
        - 
            Distinguishing and phenotype monitoring of traumatic brain injury and post-concussion syndrome including chronic migraine in serum of Iraq and Afghanistan war veterans. PLoS One. 2019; 14(4):e0215762.
            
            
                Score: 0.017
            
         
        
        - 
            Distinguishing neurocysticercosis epilepsy from epilepsy of unknown etiology using a minimal serum mass profiling platform. Exp Parasitol. 2018 Sep; 192:98-107.
            
            
                Score: 0.016
            
         
        
        - 
            Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PLoS One. 2015; 10(2):e0118933.
            
            
                Score: 0.012
            
         
        
        - 
            Biomarker identification in human pancreatic cancer sera. Pancreas. 2008 Jan; 36(1):61-9.
            
            
                Score: 0.008